A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Clinical trial NCT05396300 · COMPLETED
Trial details
- NCT number
- NCT05396300
- Sponsor
- Weijia Fang, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2026-06-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.